Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor
Rakesh K. Jain, Nina Safabakhsh, Axel Sckell et al. · Proceedings of the National Academy of Sciences · 1998
The sequence of events that leads to tumor vessel regression and the functional characteristics of these vessels during hormone-ablation therapy are not known. This is because of the lack of an appropriate animal model and monitoring technology. By using in vivo microscopy and in situ molecular analysis of the androgen-dependent Shionogi carcinoma grown in severe combined immunodeficient mice, we show that castration of these mice leads to tumor regression and a concomitant decrease in vascular endothelial growth factor (VEGF) expression. Androgen withdrawal is known to induce apoptosis in Shionogi tumor cells. Surprisingly, tumor endothelial cells begin to undergo apoptosis before neoplastic cells, and rarefaction of tumor vessels precedes the decrease in tumor size. The regressing vessels begin to exhibit normal phenotype, i.e., lower diameter, tortuosity, vascular permeability, and leukocyte adhesion. Two weeks after castration, a second wave of angiogenesis and tumor growth begins with a concomitant increase in VEGF expression. Because human tumors often relapse following hormone-ablation therapy, our data suggest that these patients may benefit from combined anti-VEGF therapy.
Cited by 373 works. doi:10.1073/pnas.95.18.10820
Authors
References
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
- Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
- The Biology of Vascular Endothelial Growth Factor
- Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
- Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
- Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
- WNTs modulate cell fate and behavior during vertebrate development
- Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice.